209 related articles for article (PubMed ID: 22552893)
1. Extensively drug-resistant Pseudomonas aeruginosa: risk of bloodstream infection in hospitalized patients.
Peña C; Gómez-Zorrilla S; Suarez C; Dominguez MA; Tubau F; Arch O; Oliver A; Pujol M; Ariza J
Eur J Clin Microbiol Infect Dis; 2012 Oct; 31(10):2791-7. PubMed ID: 22552893
[TBL] [Abstract][Full Text] [Related]
2. Bacteraemia due to extensively drug-resistant Pseudomonas aeruginosa sequence type 235 high-risk clone: Facing the perfect storm.
Recio R; Villa J; Viedma E; Orellana MÁ; Lora-Tamayo J; Chaves F
Int J Antimicrob Agents; 2018 Aug; 52(2):172-179. PubMed ID: 29621591
[TBL] [Abstract][Full Text] [Related]
3. Characterization of clinical extensively drug-resistant Pseudomonas aeruginosa in the Hunan province of China.
Li J; Zou M; Dou Q; Hu Y; Wang H; Yan Q; Liu WE
Ann Clin Microbiol Antimicrob; 2016 May; 15(1):35. PubMed ID: 27215335
[TBL] [Abstract][Full Text] [Related]
4. Acute Inflammatory Response of Patients with Pseudomonas aeruginosa Infections: A Prospective Study.
Gómez-Zorrilla S; Morandeira F; Castro MJ; Tubau F; Periche E; Cañizares R; Dominguez MA; Ariza J; Peña C
Microb Drug Resist; 2017 Jun; 23(4):523-530. PubMed ID: 27754817
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology and risk factors of extensively drug-resistant Pseudomonas aeruginosa infections.
Palavutitotai N; Jitmuang A; Tongsai S; Kiratisin P; Angkasekwinai N
PLoS One; 2018; 13(2):e0193431. PubMed ID: 29470531
[TBL] [Abstract][Full Text] [Related]
6. Influence of virulence genotype and resistance profile in the mortality of Pseudomonas aeruginosa bloodstream infections.
Peña C; Cabot G; Gómez-Zorrilla S; Zamorano L; Ocampo-Sosa A; Murillas J; Almirante B; Pomar V; Aguilar M; Granados A; Calbo E; Rodríguez-Baño J; Rodríguez-López F; Tubau F; Martínez-Martínez L; Oliver A;
Clin Infect Dis; 2015 Feb; 60(4):539-48. PubMed ID: 25378459
[TBL] [Abstract][Full Text] [Related]
7. An outbreak of extremely drug-resistant Pseudomonas aeruginosa in a tertiary care pediatric hospital in Italy.
Ciofi Degli Atti M; Bernaschi P; Carletti M; Luzzi I; García-Fernández A; Bertaina A; Sisto A; Locatelli F; Raponi M
BMC Infect Dis; 2014 Sep; 14():494. PubMed ID: 25209325
[TBL] [Abstract][Full Text] [Related]
8. Risk Factors and Outcomes of Antibiotic-resistant Pseudomonas aeruginosa Bloodstream Infection in Adult Patients With Acute Leukemia.
Zhao Y; Lin Q; Liu L; Ma R; Chen J; Shen Y; Zhu G; Jiang E; Mi Y; Han M; Wang J; Feng S
Clin Infect Dis; 2020 Dec; 71(Suppl 4):S386-S393. PubMed ID: 33367574
[TBL] [Abstract][Full Text] [Related]
9. Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality.
Tumbarello M; Repetto E; Trecarichi EM; Bernardini C; De Pascale G; Parisini A; Rossi M; Molinari MP; Spanu T; Viscoli C; Cauda R; Bassetti M
Epidemiol Infect; 2011 Nov; 139(11):1740-9. PubMed ID: 21226988
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial therapy and control of multidrug-resistant Pseudomonas aeruginosa bacteremia in a teaching hospital in Taiwan.
Leung CH; Wang NY; Liu CP; Weng LC; Hsieh FC; Lee CM
J Microbiol Immunol Infect; 2008 Dec; 41(6):491-8. PubMed ID: 19255693
[TBL] [Abstract][Full Text] [Related]
11. Prevalence, resistance mechanisms, and susceptibility of multidrug-resistant bloodstream isolates of Pseudomonas aeruginosa.
Tam VH; Chang KT; Abdelraouf K; Brioso CG; Ameka M; McCaskey LA; Weston JS; Caeiro JP; Garey KW
Antimicrob Agents Chemother; 2010 Mar; 54(3):1160-4. PubMed ID: 20086165
[TBL] [Abstract][Full Text] [Related]
12. Clinical and bacterial characteristics of Pseudomonas aeruginosa affecting the outcome of patients with bacteraemic pneumonia.
Recio R; Viedma E; González-Bodí S; Villa J; Orellana MÁ; Mancheño-Losa M; Lora-Tamayo J; Chaves F
Int J Antimicrob Agents; 2021 Dec; 58(6):106450. PubMed ID: 34644604
[TBL] [Abstract][Full Text] [Related]
13. Nosocomial spread of class 1 integron-carrying extensively drug-resistant Pseudomonas aeruginosa isolates in a Thai hospital.
Kiddee A; Henghiranyawong K; Yimsabai J; Tiloklurs M; Niumsup PR
Int J Antimicrob Agents; 2013 Oct; 42(4):301-6. PubMed ID: 23845503
[TBL] [Abstract][Full Text] [Related]
14. Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain.
Del Barrio-Tofiño E; López-Causapé C; Cabot G; Rivera A; Benito N; Segura C; Montero MM; Sorlí L; Tubau F; Gómez-Zorrilla S; Tormo N; Durá-Navarro R; Viedma E; Resino-Foz E; Fernández-Martínez M; González-Rico C; Alejo-Cancho I; Martínez JA; Labayru-Echverria C; Dueñas C; Ayestarán I; Zamorano L; Martinez-Martinez L; Horcajada JP; Oliver A
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28874376
[TBL] [Abstract][Full Text] [Related]
15. Clinical Predictive Model of Multidrug Resistance in Neutropenic Cancer Patients with Bloodstream Infection Due to Pseudomonas aeruginosa.
Gudiol C; Albasanz-Puig A; Laporte-Amargós J; Pallarès N; Mussetti A; Ruiz-Camps I; Puerta-Alcalde P; Abdala E; Oltolini C; Akova M; Montejo M; Mikulska M; Martín-Dávila P; Herrera F; Gasch O; Drgona L; Paz Morales H; Brunel AS; García E; Isler B; Kern WV; Morales I; Maestro-de la Calle G; Montero M; Kanj SS; Sipahi OR; Calik S; Márquez-Gómez I; Marin JI; Gomes MZR; Hemmatti P; Araos R; Peghin M; Del Pozo JL; Yáñez L; Tilley R; Manzur A; Novo A; Carratalà J;
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015035
[TBL] [Abstract][Full Text] [Related]
16. Genetic markers of widespread extensively drug-resistant Pseudomonas aeruginosa high-risk clones.
Cabot G; Ocampo-Sosa AA; Domínguez MA; Gago JF; Juan C; Tubau F; Rodríguez C; Moyà B; Peña C; Martínez-Martínez L; Oliver A;
Antimicrob Agents Chemother; 2012 Dec; 56(12):6349-57. PubMed ID: 23045355
[TBL] [Abstract][Full Text] [Related]
17. Virulence factors and integrons are associated with MDR and XDR phenotypes in nosocomial strains of Pseudomonas aeruginosa in a Venezuelan university hospital.
Rodulfo H; Arcia A; Hernández A; Michelli E; Martinez DDV; Guzman M; Sharma A; Donato M
Rev Inst Med Trop Sao Paulo; 2019; 61():e20. PubMed ID: 30970111
[TBL] [Abstract][Full Text] [Related]
18. Diverse Genetic Background of Multidrug-Resistant Pseudomonas aeruginosa from Mainland China, and Emergence of an Extensively Drug-Resistant ST292 Clone in Kunming.
Fan X; Wu Y; Xiao M; Xu ZP; Kudinha T; Bazaj A; Kong F; Xu YC
Sci Rep; 2016 May; 6():26522. PubMed ID: 27198004
[TBL] [Abstract][Full Text] [Related]
19. Molecular epidemiology of Pseudomonas aeruginosa isolated from infected ICU patients: a French multicenter 2012-2013 study.
Slekovec C; Robert J; van der Mee-Marquet N; Berthelot P; Rogues AM; Derouin V; Cholley P; Thouverez M; Hocquet D; Bertrand X
Eur J Clin Microbiol Infect Dis; 2019 May; 38(5):921-926. PubMed ID: 30826996
[TBL] [Abstract][Full Text] [Related]
20. Weighting the impact of virulence on the outcome of Pseudomonas aeruginosa bloodstream infections.
Sánchez-Diener I; Zamorano L; Peña C; Ocampo-Sosa A; Cabot G; Gómez-Zorrilla S; Almirante B; Aguilar M; Granados A; Calbo E; Rodriguez-Baño J; Rodríguez-López F; Tubau F; Martínez-Martínez L; Navas A; Oliver A
Clin Microbiol Infect; 2020 Mar; 26(3):351-357. PubMed ID: 31288102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
